These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26871282)

  • 41. Expression and clinical significance of estrogen-regulated long non-coding RNAs in estrogen receptor α-positive ovarian cancer progression.
    Qiu JJ; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Oncol Rep; 2014 Apr; 31(4):1613-22. PubMed ID: 24481591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma.
    Zhou J; Gong G; Tan H; Dai F; Zhu X; Chen Y; Wang J; Liu Y; Chen P; Wu X; Wen J
    Oncol Rep; 2015 Jun; 33(6):2915-23. PubMed ID: 25962395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Up-Regulation of miR-204 Enhances Anoikis Sensitivity in Epithelial Ovarian Cancer Cell Line Via Brain-Derived Neurotrophic Factor Pathway In Vitro.
    Yan H; Wu W; Ge H; Li P; Wang Z
    Int J Gynecol Cancer; 2015 Jul; 25(6):944-52. PubMed ID: 25962115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.
    Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP
    Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R.
    Li J; Li D; Zhang W
    Oncol Rep; 2016 Mar; 35(3):1671-9. PubMed ID: 26708715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-215 functions as a tumor suppressor in epithelial ovarian cancer through regulation of the X-chromosome-linked inhibitor of apoptosis.
    Ge G; Zhang W; Niu L; Yan Y; Ren Y; Zou Y
    Oncol Rep; 2016 Mar; 35(3):1816-22. PubMed ID: 26676658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysregulated estrogen receptor signaling in the hypothalamic-pituitary-ovarian axis leads to ovarian epithelial tumorigenesis in mice.
    Laws MJ; Kannan A; Pawar S; Haschek WM; Bagchi MK; Bagchi IC
    PLoS Genet; 2014 Mar; 10(3):e1004230. PubMed ID: 24603706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer.
    Cao Y; Shi H; Ren F; Jia Y; Zhang R
    Exp Cell Res; 2017 Oct; 359(1):185-194. PubMed ID: 28754469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.
    Bi L; Yang Q; Yuan J; Miao Q; Duan L; Li F; Wang S
    Oncol Rep; 2016 Nov; 36(5):2563-2570. PubMed ID: 27571744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.
    Liu W; Rodgers GP
    Cancer Metastasis Rev; 2016 Jun; 35(2):201-12. PubMed ID: 27178440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer.
    Hu Z; Zhu L; Tan M; Cai M; Deng L; Yu G; Liu D; Liu J; Lin B
    Biochimie; 2015 Feb; 109():42-8. PubMed ID: 25500588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-181 Functions as an Antioncogene and Mediates NF-κB Pathway by Targeting RTKN2 in Ovarian Cancers.
    Lin Z; Li D; Cheng W; Wu J; Wang K; Hu Y
    Reprod Sci; 2019 Aug; 26(8):1071-1081. PubMed ID: 30309296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway.
    Li L; Zhao J; Huang S; Wang Y; Zhu L; Cao Y; Xiong J; Deng J
    Gene; 2018 Jan; 641():240-247. PubMed ID: 29045821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1.
    Ge T; Yin M; Yang M; Liu T; Lou G
    Cell Physiol Biochem; 2014; 34(6):2209-20. PubMed ID: 25562167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
    Zhao J; Xu T; Wang F; Cai W; Chen L
    Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulation of miR-874-3p and miR-874-5p inhibits epithelial ovarian cancer malignancy via SIK2.
    Xia B; Lin M; Dong W; Chen H; Li B; Zhang X; Hou Y; Lou G
    J Biochem Mol Toxicol; 2018 Aug; 32(8):e22168. PubMed ID: 30004169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.
    Shen N; Huang X; Li J
    Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
    Wang A; Jin C; Li H; Qin Q; Li L
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation.
    Bellissimo T; Ganci F; Gallo E; Sacconi A; Tito C; De Angelis L; Pulito C; Masciarelli S; Diso D; Anile M; Petrozza V; Giangaspero F; Pescarmona E; Facciolo F; Venuta F; Marino M; Blandino G; Fazi F
    Mol Cancer; 2017 May; 16(1):88. PubMed ID: 28486946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.